Tuesday, December 27, 2011

Isotroin Capsules | Generic Accutane | Dosage | Uses | Side effects

Isotroin Capsules (Generic Accutane) - Active Ingredient And Chemical structure

The active ingredient contained in Isotroin Capsules is Isotretinoin. Isotretinoin, a retinoid, is a yellow to orange crystalline powder with a molecular weight of 300.44. It is available as Isotroin Capsules (Generic Accutane) in 10 mg and 20 mg capsules for oral administration.The structure is shown below
Structure Of Isotretinoin



Isotroin Capsules - Uses

Accutane in the form of Isotroin Capsules is used for the treatment of severe recalcitrant nodular acne. Nodules are inflammatory lesions with a diameter of 5 mm or greater. The nodules may become suppurative or hemorrhagic.


Generic Forms and Brand names of Accutane

Isotroin Capsules manufactured by Cipla Ltd., India is an effective treatment for moderate to severe acne that has failed other therapies. Accutane which has the active ingredient Isotretinoin is also sold as Sotret, Claravis, Amnesteem, Roaccutane, Clarus, Decutan, Isotane, Izotek, Oratane, Isotret and under various other brand names.


Isotroin Capsules - Preparations

Isotroin Capsules (Generic Accutane) is available as tablets of 10 mg and 20 mg.


Isotroin Capsules - Storage Requirements

Isotroin Capsules are to be stored at controlled room temperature (15°C to 30°C). Protect from light. Store away from heat and moisture.


Isotroin Capsules (Generic Accutane) - Contraindications

Isotroin Capsules (Generic Accutane) is contraindicated in patients who are hypersensitive to Isotretinoin or any inactive ingredient present in this medication. Generic Accutane should not be given to patients who are sensitive to parabens, which are used as preservatives in the gelatin capsule.


Isotroin Capsules (Generic Accutane) - Warnings

Isotroin Capsules (Generic Accutane) must not be used by female patients who are or may become pregnant. There is an extremely high risk that severe birth defects will result if pregnancy occurs while taking Accutane in any amount, even for short periods of time. Potentially any fetus exposed during pregnancy can be affected. There are no accurate means of determining whether an exposed fetus has been affected.
As there are significant adverse effects associated with its use, Isotroin Capsules should be reserved for patients with severe nodular acne who are unresponsive to conventional therapy, including systemic antibiotics.


Isotroin Capsules (Generic Accutane) - Dosage

Generic Accutane should always be administered with a meal. The recommended dosage range for Isotroin Capsules is 0.5 to 1.0 mg/kg/day given in two divided doses with food for 15 to 20 weeks.
In studies which compared 0.1, 0.5, and 1.0 mg/kg/day, it was found that all dosages provided initial clearing of the disease, but there was a greater need for retreatment with the lower dosages. During treatment, the Generic Accutane dose may be adjusted according to response of the disease and/or the appearance of clinical side effects — some of which may be dose related.


Side Effects Of Isotroin Capsules (Generic Accutane)

The most common side effects of Isotroin Capsules are listed below:
Body as a Whole
allergic reactions, including vasculitis, systemic hypersensitivity, edema, fatigue, lymphadenopathy, weight loss
Cardiovascular
palpitation, tachycardia, vascular thrombotic disease, stroke
Endocrine/Metabolic
hypertriglyceridemia, alterations in blood sugar levels
Gastrointestinal
inflammatory bowel disease, hepatitis, pancreatitis, bleeding and inflammation of the gums, colitis, esophagitis/esophageal ulceration, ileitis, nausea, other nonspecific gastrointestinal symptoms
Hematologic
allergic reactions, anemia, thrombocytopenia, neutropenia, rare reports of agranulocytosis.
Musculoskeletal
skeletal hyperostosis, calcification of tendons and ligaments, premature epiphyseal closure, decreases in bone mineral density, musculoskeletal symptoms including back pain, myalgia, and arthralgia, transient pain in the chest, arthritis, tendonitis, other types of bone abnormalities, elevations of CPK/rare reports of rhabdomyolysis.
Neurological
pseudotumor cerebri, dizziness, drowsiness, headache, insomnia, lethargy, malaise, nervousness, paresthesias, seizures, stroke, syncope, weakness
Psychiatric
suicidal ideation, suicide attempts, suicide, depression, psychosis, aggression, violent behaviors, emotional instability
Reproductive System
abnormal menses
Respiratory
bronchospasms (with or without a history of asthma), respiratory infection, voice alteration
Skin and Appendages
acne fulminans, alopecia (which in some cases persists), bruising, cheilitis (dry lips), dry mouth, dry nose, dry skin, epistaxis, eruptive xanthomas, erythema multiforme, flushing, fragility of skin, hair abnormalities, hirsutism, hyperpigmentation and hypopigmentation, infections (including disseminated herpes simplex), nail dystrophy, paronychia, peeling of palms and soles, photoallergic/photosensitizing reactions, pruritus, pyogenic granuloma, rash (including facial erythema, seborrhea, and eczema), Stevens-Johnson syndrome, sunburn susceptibility increased, sweating, toxic epidermal necrolysis, urticaria, vasculitis (including Wegener’s granulomatosis), abnormal wound healing
Hearing
hearing impairment, tinnitus.
Vision
corneal opacities, decreased night vision which may persist, cataracts, color vision disorder, conjunctivitis, dry eyes, eyelid inflammation, keratitis, optic neuritis, photophobia, visual disturbances
Urinary System
glomerulonephritis, nonspecific urogenital findings


Further Information

Prescribing Information